Eupraxia Pharmaceuticals, Inc. EPRX 深 沪
等待开盘 03-28 09:30:00 美东时间
6.72
-0.130
-1.90%
华盛通- 最 高8.32
- 今 开6.86
- 成交量 3.50万股
- 最 低 6.71
- 昨 收 6.85
- 总市值 0
- 52周最高 9.32
- 市盈率 静 --
- 换手率 Infinity.00%
- 52周最低 2.6801
- 委 比 -50.37%
- 总股本 --
- 历史最高 9.32
- 量 比 0.36
- 振 幅 23.50%
- 历史最低 2.215
- 每 手 1
- 风险率
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Eupraxia Pharmaceuticals Boasts $900 Million Peak Sales Potential: Analyst
William Blair starts Eupraxia at Outperform as the analyst flags unmet need and sizable market potential.
03-24 01:59
Eupraxia Pharma将公开发行1270万股筹集约7000万美元
Eupraxia Pharmaceuticals（NASDAQ：EPRX）将其1270万股公开发行价格定为每股5.50美元，筹集约7000万美元。所筹资金将用于推进其产品管线及相关商业活动。 海量资讯、精准解读，尽在新浪财经APP 责任编辑：张俊 SF065
2025-09-23 23:21
Eupraxia Pharmaceuticals Announces Voting Results from Annual General and Special Meeting of Shareholders
Eupraxia Pharmaceuticals Inc. announced the results of its Annual General and Special Meeting of Shareholders held on June 2, 2025. All six nominees for the Board of Directors were elected with overwhelming support, and shareholders approved the reappointment of KPMG LLP as auditors, the 2025 Omnibus Incentive Plan, and the re-pricing of certain stock options. The meeting was a success, reflecting strong shareholder confidence in the Company's leadership and strategic direction.
2025-06-02 22:30
